Multi-Cancer Early Detection (MCED) testing is an emerging approach that aims to identify signals associated with multiple cancers through a single blood sample. As awareness of MCED grows, some individuals may wonder whether this type of screening could be relevant to them.

This article is intended to support general understanding and informed discussion, rather than to provide medical advice or recommendations. Decisions about cancer screening should always be made in consultation with qualified healthcare professionals.

MCED as a Screening Approach

MCED is generally designed as a screening tool, rather than a diagnostic test. In clinical practice, screening tests are used to identify individuals who may need further medical evaluation, rather than to confirm the presence or absence of disease.

As with other screening approaches:

• A negative result may suggest that no detectable cancer-associated signal was identified at the time of testing, but it cannot rule out future cancer development.
• An intermediate result indicates a borderline signal where there is insufficient evidence to confirm the presence of cancer. A repeat test may be recommended, along with annual health check-ups and medical consultation if any early warning signs appear.
• A positive result may indicate a higher likelihood of a cancer-associated signal and warrants prompt follow-up with appropriate diagnostic evaluation; it is not a confirmed diagnosis.
• Some individuals may experience emotional or psychological stress related to uncertain or unexpected screening results.

For these reasons, MCED testing may not be appropriate for everyone.

MCED testing may not be appropriate or useful for everyone

Individuals Who May Consider MCED Testing

MCED testing is not designed for universal use. In some situations, it may be discussed as a supplementary option alongside established screening programs.

Adults in Midlife and Older Age Groups

Cancer risk may increase with age (1). For this reason, MCED testing is sometimes discussed with adults aged 40 and above who have no signs or symptoms of cancer.

In these individuals, MCED may be considered as an additional screening layer, particularly for cancers that do not currently have widely implemented screening programs.

Cancer risk may increase with age

Individuals with Factors Associated with Higher Cancer Risk

Some people may have characteristics or medical histories that are associated with a higher likelihood of developing cancer. In such cases, MCED testing may be discussed as part of a broader preventive care conversation.

Younger individuals with high-risk factors, such as:

• • Heavy smoking: ≥20 pack-years (2)
  • Heavy alcohol consumption: ≥15 drinks/week (men) or ≥8 drinks/week (women) (3)
  • Hereditary cancer risk: Positive for genes like BRCA1, BRCA2, TP53 (4)
  • Chronic liver disease: Hepatitis B or C infection (5)
  • Family history of cancer: First-degree relatives diagnosed with cancer (6)

The relevance of MCED in these contexts can vary and should be evaluated on an individual basis.

Some people may have factors associated with a higher likelihood of developing cancer

Individuals with Limitations or Gaps in Conventional Screening

Conventional cancer screening methods, such as imaging-based or organ-specific tests, have well-established benefits but do not cover all cancer types.

In some circumstances, MCED may be discussed with individuals who:

• Have physical or biological factors that may may affect the accuracy of certain screening tests
• Have concerns about cancers that arise between routine screening intervals
• Are unable or unwilling to undergo invasive screening procedures
• Are interested in broader screening for cancers without established population-level screening programs

MCED is generally positioned as complementary, rather than as a substitute for standard screening.

Individuals with Limitations or Gaps in Conventional Screening

Role of Healthcare Professionals in Decision-Making

Because MCED testing involves complementarity and potential downstream evaluation, discussions with healthcare professionals are an essential part of the decision-making process.

Healthcare professionals may help individuals consider:

• Personal medical history and risk profile
• Potential benefits and limitations of screening
• Practical implications of follow-up testing
• Individual values, preferences, and tolerance for uncertainty

This collaborative process is often referred to as shared decision-making, and it aims to support choices that are medically appropriate and personally acceptable.

MCED Within Preventive Healthcare

In some healthcare settings, MCED testing may be explored as part of a broader preventive care strategy. This may include:

• Health assessments conducted under medical supervision
• Monitoring strategies for individuals with elevated risk
• Structured wellness programs guided by clinicians

A negative screening result should not be interpreted as an assurance of future health, nor should it replace ongoing participation in recommended screening programs.

Key Points to Consider

• MCED is an emerging screening approach, not a diagnostic test
• It is not intended to replace established cancer screening methods
• Its potential role may differ depending on individual risk and context
• Decisions about MCED testing should be made with healthcare professionals
• Choosing not to pursue MCED testing can be an appropriate decision

The purpose of cancer screening is to support early identification and informed care — not to eliminate uncertainty. Understanding the potential role and limitations of MCED may help individuals engage more effectively in conversations about their health.

Reference

(1) Sharma et al., 2024. The Lancet Regional Health – Southeast Asia 21, 100333.
(2) Chen et al., 2021. American Journal of Otolaryngology 42, 102915.
(3) Connor et al., 2017. Addiction 112, 222–228.
(4) Garber et al., 2005. JCO 23, 276–292.
(5) Petruzziello et al., 2018. TOVJ 12, 26–32.
(6) Brewer et al., 2017. Breast Cancer Research and Treatment 165, 193–200.

Disclaimer

This content is for educational purposes only and does not constitute medical advice. Multi-Cancer Early Detection (MCED) tests should be considered and ordered by licensed healthcare professionals. Availability and regulatory permissions vary by country.